10 Best Healthcare Stocks to Buy According to Billionaires

4. Johnson & Johnson (NYSE:JNJ)

Number of Billionaire Investors: 18

Value of Billionaire Holdings: $2.9 billion

Johnson & Johnson (NYSE:JNJ) conducts research, develops, manufactures, and sells a range of healthcare products worldwide, operating through its Innovative Medicine and MedTech segments. On March 21, JNJ announced plans to invest over $55 billion in US manufacturing, research, development, and technology over the next four years, a 25% increase from the previous investment period. The company projects that these investments will contribute more than $100 billion annually to the US economy. As part of this expansion, Johnson & Johnson (NYSE:JNJ) will build three advanced manufacturing facilities in addition to an existing site in North Carolina.

In 2024, Johnson & Johnson (NYSE:JNJ) saw a 7% increase in operational sales, excluding its COVID-19 vaccine. SPRAVATO surpassed $1 billion in annual sales, bringing the firm’s total number of billion-dollar revenue platforms to 26. Its Innovative Medicine segment exceeded $14 billion in sales for the third consecutive quarter, with 10 brands achieving double-digit growth. In Q4 2024, JNJ’s net earnings amounted to $3.4 billion. By the end of 2024, the company held around $25 billion in cash and marketable securities, with $37 billion in debt, resulting in a net debt position of about $12 billion. A strong focus on cash flow helped JNJ generate approximately $20 billion in free cash flow in 2024, an increase of $1.6 billion compared to 2023.

On March 25, Johnson & Johnson (NYSE:JNJ) introduced the FDA-cleared Dualto energy system, a surgical platform that integrates multiple energy modalities for open and minimally invasive procedures. Designed to work with the company’s Polyphonic Fleet software for device management, Dualto offers an advanced surgical solution. Looking ahead, JNJ plans to integrate Dualto with its highly anticipated Ottava surgical robot.

Johnson & Johnson (NYSE:JNJ) is considered one of the best healthcare stocks, attracting investments from 18 billionaires.